Continuous Glucose Monitoring Systems for Diabetes Management
Developer of long and short-term continuous glucose monitoring devices.nIPO: DexCom (NASDAQ SYMBOL: DXCM)
Dexcom secures CE-Mark for G6 CGM System
June 14, 2018
Wedbush Analysts Give DexCom a $73.00 Price Target $DXCM http://t.co/ZGZa0EC1xi via @RatingsNetwork
March 3, 2015